Our Company
Our History
Founded in January 2018 as a University of Toronto/MaRS Innovation UTEST startup.
Our Focus
We are developing new molecular matter as leads for the cure of neurodegenerative diseases including ALS, Alzheimer's and Parkinson's diseases
Our Location
We are located at the JLabs Toronto site in the MaRS West Tower
Our Team
Peter Lewis PhD FCAHS CEO
Peter Lewis PhD FCAHS CEO
Peter Lewis PhD FCAHS CEO
Emeritus Professor of Biochemistry University of Toronto
50 years of research experience
25 years of science leadership
G. Angus McQuibban PhD CSO
Peter Lewis PhD FCAHS CEO
Peter Lewis PhD FCAHS CEO
Associate Professor of Biochemistry University of Toronto
25 years of research experience
John Reid PhD Executive In Residence
John Reid PhD Executive In Residence
John Reid PhD Executive In Residence
30 years of drug discovery and business
development experience
Naomi Visanji PhD Senior Scientist
John Reid PhD Executive In Residence
John Reid PhD Executive In Residence
Toronto Western Hospital
Edmond J. Safra program in Parkinson's disease
Adjunct Lecturer Laboratory Medicine and Pathobiology